Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder.
Koopal C, Marais AD, Visseren FL.
Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):133-139. doi: 10.1097/MED.0000000000000316.
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
Heidemann BE, Koopal C, Baass A, Defesche JC, Zuurbier L, Mulder MT, Roeters van Lennep JE, Riksen NP, Boot C, Marais AD, Visseren FLJ.
Clin Genet. 2022 Oct;102(4):253-261. doi: 10.1111/cge.14185. Epub 2022 Aug 22.
Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
Havel RJ.
Med Clin North Am. 1982 Mar;66(2):441-54. doi: 10.1016/s0025-7125(16)31429-8.
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.
Koopal C, Marais AD, Westerink J, Visseren FL.
J Clin Lipidol. 2017 Jan-Feb;11(1):12-23.e1. doi: 10.1016/j.jacl.2016.10.001. Epub 2016 Oct 13.
The clinical and laboratory investigation of dysbetalipoproteinemia.
Boot CS, Luvai A, Neely RDG.
Crit Rev Clin Lab Sci. 2020 Nov;57(7):458-469. doi: 10.1080/10408363.2020.1745142. Epub 2020 Apr 7.
Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
Smelt AH, de Beer F.
Semin Vasc Med. 2004 Aug;4(3):249-57. doi: 10.1055/s-2004-861492.
Familial dysbetalipoproteinemia: a genetically heterogenous disease caused by mutations of the ligand apolipoprotein E.
Vermeer BJ, Frants RR, Havekes LM.
J Invest Dermatol. 1992 Jun;98(6 Suppl):57S-60S. doi: 10.1111/1523-1747.ep12462212.
Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
Bea AM, Cenarro A, Marco-Bened V, Laclaustra M, Martn C, Ibarretxe D, Pint X, Arrobas T, Vials C, Civeira F, Olmos S.
Clin Chem. 2023 Feb 1;69(2):140-148. doi: 10.1093/clinchem/hvac213.
Dysbetalipoproteinemia: an extreme disorder of remnant metabolism.
Marais D.
Curr Opin Lipidol. 2015 Aug;26(4):292-7. doi: 10.1097/MOL.0000000000000192.
Dietary recommendations for dysbetalipoproteinemia: A need for better evidence.
Paquette M, Blais C, Fortin A, Bernard S, Baass A.
J Clin Lipidol. 2023 Jul-Aug;17(4):549-556. doi: 10.1016/j.jacl.2023.05.101. Epub 2023 May 25.
